Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000170377 | SCV000222792 | likely pathogenic | Cockayne syndrome type 2 | 2012-09-07 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000668158 | SCV000792712 | likely pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2 | 2017-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001046396 | SCV001210296 | pathogenic | not provided | 2023-07-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 190159). This premature translational stop signal has been observed in individual(s) with clinical features of Cockayne syndrome (PMID: 28170084). This variant is present in population databases (rs774791374, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Leu700Valfs*60) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). |